As such we recommend a prospective study using CEA preoperatively to accurately correlate the level of CEA with risk of lymph nodes metastasis, and to determine the cut-off value of CEA. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.